Note: Ingredients listed on restricted chemical lists
EC/CAS
1310-73-2
Name of the chemical
sodium hydroxide
Concentration
0.5 - 1.9
EC/CAS
5064-31-3
Name of the chemical
Trisodium nitrilotriacetate
Concentration
0.5 - 2
EC/CAS
7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
53 - 59
General Information
Revision date
2011-09-29
Product name
Dissolvine E-39
Product Synonyms
Tetrasodium EDTA
Chemical name
Ethylenediaminetetraacetic acid, tetrasodium salt (39% aqueous solution)
Emergency telephone
CHEMTREC
Icons in SDS
Company Information
company name
Akzo Nobel Functional Chemicals LLC
GHS Information
Signal word
WARNING
Section 2
SECTION 2: Hazards identification
OSHA EMERGENCY This material is considered hazardous by the OSHA Hazard Communication Standard OVERVIEW [29 CFR 1910.1200] Harmful if inhaled. May be harmful if swallowed. Causes eye irritation. WARNING ! May cause skin and respiratory tract irritation. Corrosive to aluminum. Contains material which may cause kidney damage and cancer, based on animal data.
Appearance/Odor
Clear yellow liquid with a slight ammonia odor.
Potential health effects
See Section 11 for additional information] Primary Route(s) of Eye contact, skin contact and inhalation Exposure Acute Exposure Inhalation: Exposure to an excessive concentration of vapors, mist, fumes or aerosols may cause respiratory tract discomfort and/or mild irritation. Skin Contact: May cause skin irritation. Eye Contact: Eye contact causes irritation. Ingestion: This product may be harmful if swallowed. Carcinogenicity This product and its components are not listed as known carcinogens or potential carcinogens by IARC (International Agency for Research on Cancer), ACGIH (American Conference of Governmental Industrial Hygienists), NTP (National Toxicology Program), OSHA (U.S. Occupational Safety & Health Administration) and EPA (U.S. Environmental protection Agency). However, Nitrilotriacetic acid (NTA) and its salts were determined to be “possibly carcinogenic to humans” (Group 2B) by IARC, a compound which “may reasonably be anticipated to be a carcinogen” by NTP and a “select carcinogen” by OSHA. (CONTINUED)
Potential chronic health
EDTA and its sodium salts caused birth defects in some animal studies in the presence of Developmental Toxicity maternal toxicity.
Medical Conditions Generally Aggravated by Exposure
Zinc deficiency may be aggravated by systemic exposure to EDTA and its sodium salts.
Environmental effects
See Section 12 for additional information] Aquatic Toxicity This product is not expected to be harmful to aquatic life, based on available data with related materials.